Clinical Trial Update: A Study to Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis

View source ↗

Summary

This completed clinical trial evaluated the long-term safety and effectiveness of sequential mitoxantrone (Novantrone) therapy followed by glatiramer acetate (C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• COPAXONE (GLATIRAMER ACETATE)
• Novantrone (mitoxantrone)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Relapsing Remitting Multiple Sclerosis | Status: COMPLETED